PMID: 9525106Apr 3, 1998Paper

Silymarin inhibits the development of diet-induced hypercholesterolemia in rats

Planta medica
V KrecmanVilím Simánek

Abstract

To study the ability of silymarin, a standardized mixture of antioxidant flavonolignans from the medicinal plant Silybum marianum, and of silybin, the main flavonolignan of silymarin, to inhibit the development of diet-induced hypercholesterolemia the rats were fed high cholesterol diet (HCD). Silymarin or silybin were given as dietary supplements, and their influences on serum cholesterol levels were compared to those of probucol, an antioxidant hypocholesterolemic drug. Anticholesterolemic effect of silymarin was parallel to that of probucol, and dose-dependent at dietary drug concentrations of 0.1-0.5-1.0% (w/w). However, in contradistinction to probucol, silymarin caused an increase in high density lipoprotein (HDL)-cholesterol and a decrease in liver cholesterol content, changes considered to be of benefit. In addition to its anticholesterolemic effect silymarin partially prevented the HCD-induced decrease in liver reduced glutathione, an endogenous antioxidant. Silybin was not so effective as silymarin suggesting that either other constituent(s) of silymarin may be responsible for its anticholesterolemic effect or the bioavailability of silybin alone might be lower than that of silybin as a compound of silymarin.

Citations

Jun 5, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nina SkottováJitka Ulrichová
Jan 16, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nina SkottováLadislav Cvak
Sep 24, 2005·Journal of Asian Natural Products Research·Qing HuangTakashi Ikejima
Oct 1, 2007·Pakistan Journal of Biological Sciences : PJBS·Majid ShokrpourAziz Javanshir
Dec 1, 2006·Plant Foods for Human Nutrition·S Valcheva-KuzmanovaA Belcheva
Jan 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Limei WangAtanas G Atanasov
Oct 13, 2009·Toxicology Mechanisms and Methods·Khaled M M KoriemSayed A El-Toumy
Jul 11, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J OrolinP Anzenbacher
Oct 6, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Jr-Ting LeeOliver Yoa-Pu Hu
Jan 21, 2016·Oxidative Medicine and Cellular Longevity·Csaba CsonkaTamás Csont
Mar 14, 2007·Journal of Pineal Research·Saad Abdul-Rehman Hussain
Feb 27, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Kateřina ValentováJitka Ulrichová
Jun 23, 2005·Critical Reviews in Food Science and Nutrition·Paola VitaglioneVincenzo Fogliano
Jan 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alessandro FedericoCarmelina Loguercio
Jan 27, 2017·Phytotherapy Research : PTR·Aline Maria StolfAlexandra Acco
Feb 3, 2005·Bioorganic & Medicinal Chemistry Letters·José Luis Medina-FrancoJoaquín Tamariz
May 16, 2003·Phytotherapy Research : PTR·Zdenek SvageraVilím Simánek
Mar 6, 2019·Phytotherapy Research : PTR·Hamed MohammadiMohammad Hossein Rouhani
Jul 9, 2020·Canadian Journal of Physiology and Pharmacology·Nikola CikirizVladimir Jakovljevic
Sep 21, 2020·Annals of Hepatology·Karla MacDonald-RamosMarco Cerbón
Sep 3, 2020·Journal of Ethnopharmacology·Ilias MarmouziMourad Kharbach
Dec 6, 2019·Journal of Ethnopharmacology·Dongdong WangVerena M Dirsch
May 15, 2008·Journal of Agricultural and Food Chemistry·Sunny WallaceDanielle Julie Carrier
Oct 14, 2020·Journal of Agricultural and Food Chemistry·Xin WangShuai-Cheng Wu
Apr 1, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Abdoh TalebDing Qilong

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Acta Universitatis Palackianae Olomucensis Facultatis Medicae
N SkottováVilím Simánek
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Lucie SobolováK Urbánek
© 2022 Meta ULC. All rights reserved